CPC-111 phosphorylated sugar: Began dose-ranging Phase II trial, testing 75 to 300 mg/kg in 48 patients, 12 of whom will receive placebo

Cypros Pharmaceutical Corp. (CYPR), Carlsbad, Calif. Product: CPC-111 phosphorylated sugar Indication: Sickle cell crisis Status: Began dose-ranging Phase II trial, testing 75 to 300 mg/kg in 48 patie...